Drugs and Driving Research in Medicinal Drug Development

J. G. Ramaekers*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

24 Citations (Web of Science)


Medicinal drugs that cause drowsiness and inattentiveness may impair driving. The FDA recently emphasized that standardized procedures for measuring drug effects on driving are needed as part of drug registration. Here, I provide an overview of a standardized on-the-road driving test that offers maximal drug sensitivity and uses a real-life outcome measure of driver impairment that is strongly associated with crash risk.
Original languageEnglish
Pages (from-to)319-321
JournalTrends in Pharmacological Sciences
Issue number4
Publication statusPublished - Apr 2017

Cite this